1. Home
  2. HCWB vs SKYQ Comparison

HCWB vs SKYQ Comparison

Compare HCWB & SKYQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • SKYQ
  • Stock Information
  • Founded
  • HCWB 2018
  • SKYQ 2019
  • Country
  • HCWB United States
  • SKYQ United States
  • Employees
  • HCWB N/A
  • SKYQ 29
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • SKYQ
  • Sector
  • HCWB Health Care
  • SKYQ
  • Exchange
  • HCWB Nasdaq
  • SKYQ NYSE
  • Market Cap
  • HCWB 10.8M
  • SKYQ 12.9M
  • IPO Year
  • HCWB 2021
  • SKYQ N/A
  • Fundamental
  • Price
  • HCWB $4.30
  • SKYQ $0.55
  • Analyst Decision
  • HCWB Strong Buy
  • SKYQ
  • Analyst Count
  • HCWB 1
  • SKYQ 0
  • Target Price
  • HCWB $35.00
  • SKYQ N/A
  • AVG Volume (30 Days)
  • HCWB 116.1K
  • SKYQ 1.1M
  • Earning Date
  • HCWB 08-13-2025
  • SKYQ 08-14-2025
  • Dividend Yield
  • HCWB N/A
  • SKYQ N/A
  • EPS Growth
  • HCWB N/A
  • SKYQ N/A
  • EPS
  • HCWB N/A
  • SKYQ N/A
  • Revenue
  • HCWB $1,445,145.00
  • SKYQ $18,744,825.00
  • Revenue This Year
  • HCWB $178.36
  • SKYQ N/A
  • Revenue Next Year
  • HCWB N/A
  • SKYQ N/A
  • P/E Ratio
  • HCWB N/A
  • SKYQ N/A
  • Revenue Growth
  • HCWB N/A
  • SKYQ N/A
  • 52 Week Low
  • HCWB $3.55
  • SKYQ $0.48
  • 52 Week High
  • HCWB $100.80
  • SKYQ $5.49
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 42.79
  • SKYQ N/A
  • Support Level
  • HCWB $4.02
  • SKYQ N/A
  • Resistance Level
  • HCWB $4.44
  • SKYQ N/A
  • Average True Range (ATR)
  • HCWB 0.31
  • SKYQ 0.00
  • MACD
  • HCWB 0.08
  • SKYQ 0.00
  • Stochastic Oscillator
  • HCWB 31.85
  • SKYQ 0.00

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company, along with its subsidiaries, is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and the remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses. The company has one reportable segment: refined crude oil. The company refines crude oil to produce several key products, including Diesel, Liquid Asphalt, Vacuum Gas Oil (VGO), and Naphtha, each with distinct industrial applications.

Share on Social Networks: